Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33091125

Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2020 Oct 27
First author
Yonekura K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Yonekura K
      type
      Author
    2. name
      Kusumoto S
      type
      Author
    3. name
      Choi I
      type
      Author
    4. name
      Nakano N
      type
      Author
    5. name
      Ito A
      type
      Author
    6. name
      Suehiro Y
      type
      Author
    7. name
      Imaizumi Y
      type
      Author
    8. name
      Yoshimitsu M
      type
      Author
    9. name
      Nosaka K
      type
      Author
    10. name
      Ohtsuka E
      type
      Author
    11. name
      Hidaka M
      type
      Author
    12. name
      Jo T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Yonekura K
      type
      Author
    2. name
      Kusumoto S
      type
      Author
    3. name
      Choi I
      type
      Author
    4. name
      Nakano N
      type
      Author
    5. name
      Ito A
      type
      Author
    6. name
      Suehiro Y
      type
      Author
    7. name
      Imaizumi Y
      type
      Author
    8. name
      Yoshimitsu M
      type
      Author
    9. name
      Nosaka K
      type
      Author
    10. name
      Ohtsuka E
      type
      Author
    11. name
      Hidaka M
      type
      Author
    12. name
      Jo T
      type
      Author
    bibliography ids
    1. nci-bib-67cf1ab3fae2eb71317348fe
    book metadata
    content sha256
    bd7fffc10904622f4b0a042359e666e474e8b1514815bea5d919a6bb9e4435df
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2020003053
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33091125
    immutable id
    pubmed:33091125@bd7fffc10904622f4b0a042359e666e474e8b1514815bea5d919a6bb9e4435df
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    20
    name
    Blood advances
    nlm unique id
    101698425
    pages
    5133-5145
    volume
    4
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33091125
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      cb2a8e7f92fdbba11a80586f97c82e3c65970e40946756f542cf34d817b9e970
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2020 Oct 27
      precision
      day
      year
      2020
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Observational Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33091125/
      title
      Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

      Preserved source evidence · Independent clinical review pending · Not medical advice